Alimera Completes Recruitment for its Landmark NEW DAY Study

Author's Avatar
May 24, 2023

Study has Now Reached Goal of 300 Patients Enrolled to Evaluate ILUVIEN as First Line, Baseline Therapy for Diabetic Macular Edema